Regentis Biomaterials Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Regentis Biomaterials Ltd., a foreign private issuer based in Herzliya, Israel, covers the month of May 2026. The report serves to notify shareholders of the upcoming Annual General Meeting of Shareholders scheduled for July 2, 2026.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The primary update is the scheduling of the Annual General Meeting.
Guidance, Outlook, and Management Commentary
Management has announced the Annual General Meeting will be held on Thursday, July 2, 2026, at 3:00 p.m. Israel time at the offices of Amit, Pollak, Matalon & Co. in Tel Aviv. The filing includes the Notice and Proxy Statement (Exhibit 99.1) and a Proxy Card (Exhibit 99.2) to facilitate voting. No specific business outlook, guidance, or risk factors are detailed in this specific text.
Key Facts for Investor Verification
- Annual General Meeting Date: July 2, 2026.
- Meeting Time: 3:00 p.m. Israel time.
- Meeting Location: Amit, Pollak, Matalon & Co., Ramat Hachayal, Tel Aviv, Israel.
- Shareholders may vote in person or by proxy using the attached forms.
- No financial results are included in this filing; investors should refer to the most recent Form 20-F for financial data.